Why do humans have two glucocorticoids: A question of intestinal fortitude

Steroids

Volumn 102, Issue , 2015, Pages 32-38

  Morris, David J ^a,b  

^a MIRIAM HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

11 OH (allo) 5 pregnanolone; 17 Hydroxylase deficiency; 3 5 Tetrahydro corticosterone; Corticosterone; Cortisol; Intestinal flora; Kidney 11 HSD2 GALFs

Indexed keywords

11BETA HYDROXYPROGESTERONE; 11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; 17ALPHA DEHYDROXYLASE; 17ALPHA HYDROXYLASE DEFICIENCY; CORTICOSTERONE; CORTICOSTERONE DERIVATIVE; HYDROCORTISONE; OXYGENASE; POTASSIUM; UNCLASSIFIED DRUG;

ADRENAL CORTEX INSUFFICIENCY; ADRENAL GLAND; BIOCHEMICAL ANALYSIS; BLOOD PRESSURE REGULATION; CORTICOSTERONE BLOOD LEVEL; ENTEROHEPATIC CIRCULATION; ENZYME ACTIVITY; HORMONE DEFICIENCY; HORMONE METABOLISM; HORMONE RELEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROXYLATION; HYPERTENSION; INTESTINE FLORA; NONHUMAN; POTASSIUM TRANSPORT; REVIEW; SODIUM RETENTION; ANAEROBIC BACTERIUM; INTESTINE; METABOLISM; MICROBIOLOGY;

ADDISONIA; MAMMALIA;

BACTERIA, ANAEROBIC; CORTICOSTERONE; HUMANS; HYDROCORTISONE; INTESTINES;

EID: 84936946445     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2015.06.017     Document Type: Review

References (98)

1. T. Reichstein Uber Bestandteile der Nebennierenrinde zur Kenntnis des Cortico-sterons Helv. Chim. Acta 20 1937 953 965
2. H.L. Mason, W.M. Hoehn, B.F. McKenzie, and E.C. Kendall Chemical studies of the suprarenal cortex. III. Structures of compounds A, B, and H J. Biol. Chem. 120 1937 719 730
3. E. Kendall, H. Mason, W. Hoehn, and B. McKenzie The structure and physiological activity of compound B: its relationship to compound A and Reichstein's corticosterone Proc. Staff Meet. Mayo Clinic 12 1937 136 139
4. T. Reichstein, and J. von Euw Uber Bestandteile der Nebennierenrinde Isolierung der Substanzen A (Deoxy-corticosteron) Helv. Chim. Acta 21 1938 1197 1200
5. G.W. Thorn, G.F. Koepf, R.A. Lewis, and E.F. Olsen J. Clin. Invest. 19 1940 813 819
6. J.W. Ferrebee, C. Ragan, D.W. Atchley, and R.F. Loeb Endocrinology 27 360-36 1940 9
7. J.W. Conn, S.S. Fajans, L.H. Louis, and B. Johnson Metabolic and clinical effects of corticosterone (Compound B) in man J. Lab. Clin. Med. 36 1950 813
8. J.W. Conn, S.S. Fajans, and L.H. Louis Metabolic effect in man of orally and parenterally administered corticosterone (Compound B) Trans. Assoc. Am. Phys. 64 1951 269 278
9. I.E. Bush Species differences in adrenocortical secretion J. Endocrinol. 9 1953 95
10. L.L. Engel, P. Carter, and L.L. Fielding Urinary metabolites of administered corticosterone. I. Steroids liberated by glucuronidase hydrolysis J. Biol. Chem. 213 1955 99 106
11. C.J. Migeon, A.A. Sandberg, A.C. Paul, and L.T. Samuels Metabolism of 4-C14-Corticosterone in man J. Clin. Endocrinol. Metab. 16 1956 1291
12. R.E. Peterson, and C.E. Pierce The metabolism of corticosterone in man J. Clin. Invest. 39 1960 741 757
13. M.I. New, M.P. Seaman, and R.E. Peterson A method for the simultaneous determination of the secretion rates of cortisol, 11-desoxycortisol, corticosterone, 11-desoxycorticosterone and aldosterone J. Clin. Endocrinol. 29 1969 514 522
14. L.H. Sarett Partial synthesis of pregnene-4-triol-17(β), 20(β), 21-dione-3, 11 and pregnene-4-diol-17(β), 21-trione-3,11,20 monoacetate J. Biol. Chem. 162 1946 601 631
15. P.S. Hench, E.C. Kendall, C.H. Slocumb, and H.F. Polley The effects of the adrenal cortical hormone 17-hydroxy-11-dehydrocorticosterone (Compound E) on the acute phase of rheumatic fever; preliminary report Mayo Clin. Proc. 24 1949 277 297
16. R.E. Peterson The miscible pool and turnover rate of adrenocortical steroids in man Recent Prog. Hormone Res. 15 1959 231 256
17. S.A. Simpson, J.F. Tait, A. Wettstein, R. Neher, J. von Euw, O. Schindler, and T. Reichstein Aldosteron Isolierung und Eigenschaften bar Bestandteile der Nebennierenrinde und Verwandte Stoffe Helv. Chim. Acta 37 1954 1163 1171
18. T. Sandor, A.G. Fazekas, B.H. Robinson, The biosynthesis of corticosteroids throughout the vertibrates, in: I. Chester Jones, I.W. Henderson (Eds.), General, Comparative and Clinical Endocrinology of the Adrenal Cortex, vol. 1, 1976, pp. 25-142.
19. C.H.L. Shackleton, E.G. Biglieri, E. Roitman, and J. Honour Metabolism of radiolabeled corticosterone in an adult with the 17-hydroxylase deficiency syndrome J. Clin. Endocrinol. Metab. 48 1979 976 982
20. H. Eriksson, J.-A. Gustafsson, and J. Sjovall Steroids in germfree and conventional rats. 21-Dehydroxylation by intestinal microorganisms Eur. J. Biochem. 9 1969 550 554
21. V.D. Bokkenhauser, J.B. Suzuki, S.B. Polovsky, J. Winter, and W.G. Kelley Metabolism of deoxycorticosterone by human fecal flora Appl. Microbiol. 30 1975 82 90
22. J.H. Honour, J. Tourniaire, E.G. Biglieri, and C.H.L. Shackleton Urinary steroid excretion in 17-hydroxylase deficiency J. Steroid Biochem. 9 1977 495 505
23. V.D. Bokkenhauser, J. Winter, P. Dehazya, and W.G. Kelly Isolation and characterization of human fecal bacteria capable of 21-dehydroxylating corticoids Appl. Environ. Microbiol. 34 1977 571 585
24. L. Kornel, W.R. Starnes, S.R. Holl, and A. Hill Studies on steroid conjugates. Part VI. Quantitative paper chromatography of urinary corticosteroids in essential hypertension J. Clin. Endocrinol. Metab. 29 1969 1608 1617
25. H.L. Bradlow, B. Zumoff, C. Monder, H.J. Lee, and L. Hellman Isolation and identification of four new carboxylic acid metabolites of cortisol in man J. Clin. Endocrinol. Metab. 37 1973 811 818
26. L. Kornel Colocalization of 11β-hydroxysteroid dehydrogenase and mineralocorticoid receptors in cultured vascular smooth muscle cells Am. J. Hypertension 7 1994 100 103
27. M.L. Sweat, B.I. Grosser, D.L. Berliner, H.E. Swim, C.J. Nabors, and T.F. Dougherty The metabolism of cortisol and progesterone by cultured uterine fibroblasts, strain U12-705 Biochem. Biophys. Acta 28 1958 591 596
28. L.P. Romanoff, C.W. Morris, P. Welch, R.M. Rodriguez, and G. Pincus The metabolism of cortisol-4-C14 in young and elderly men. I. Secretion rate and daily excretion of tetrahydrocortisol, allotetrahydrocortisol, tetrahydrocortisone, allotetrahydrocortisone, and cortolone (20α and 20β) J. Clin. Endocrinol. Metab. 21 1961 1413 1425
29. V.B. Mahesh, and F. Ulrich Distribution of enzyme systems responsible for steroid metabolism in different tissues and subcellular fractions Nature London 184 1959 1147 1148
30. I.E. Bush Chemical and biological factors in the activity of adrenocortical steroids Pharmacol. Rev. 14 1962 317 445
31. I.E. Bush, S.A. Hunter, and R.A. Meigs Metabolism of 11-oxygenated steroids Biochem. J. 107 1968 239 257
32. C. Monder, and P.C. White 11β-Hydroxysteroid dehydrogenase Vitam. Horm. 47 1993 187 269
33. B.E. Pearson Murphy Cortisol and cortisone in human fetal development J. Steroid Biochem. 11 1979 509 513
34. P.M. Stewart, A.M. Wallace, R. Valentino, D. Burt, C.H.L. Shackleton, and C.R.W. Edwards Mineralocorticoid activity of liquorice: 11β-hydroxysteroid dehydrogenase deficiency comes of age Lancet 2 1987 821 824
35. C.R.W. Edwards, P.M. Stewart, D. Burt, L. Brett, M.A. McIntyre, W.S. Sutanto, E.R. Dekloet, and C. Monder Localization of 11β-hydroxysteroid dehydrogenase; tissue specific protector of the mineralocorticoid receptor Lancet 2 1988 986 989
36. E. Rusvai, and A. Naray-Fejes-Toth A new isoform of 11β-hydroxysteroid dehydrogenase in aldosterone target cells J. Biol. Chem. 268 1993 10717 10720
37. A.L. Albiston, V.R. Obeyesekere, R.E. Smith, and Z.S. Krozowski Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme Mol. Cell. Endocrinol. 105 1994 11 17
38. A. Naray-Fejes-Toth, and G. Naray-Fejes-Toth Subcellular localization of the type 2 11β-hydroxysteroid dehydrogenase J. Biol. Chem. 271 1996 15436 15442
39. J.W. Funder, P.T. Pearce, R. Smith, and A.I. Smith Mineralocorticoid action: target tissue specificity is enzyme, not receptor mediated Science 242 1988 583 585
40. J.R. Seckl, and B.R. Walker Minireview. 11β-hydroxysteroid dehydrogenase type 1-a tissue-specific amplifier of glucocorticoid action Endocrinology 142 2001 115 120
41. D.J. Morris, A.S. Brem, R. Ge, P.H. Jellinck, R.R. Sakai, and M.P. Hardy At the Cutting Edge. The functional roles of 11-HSD1: vascular tissue, testis and brain Mol. Cell. Endocrinol. 203 2003 1 12
42. C.R.W. Edwards Sixty years after Hench - corticosteroids and chronic inflammatory disease J. Clin. Endocrinol. Metab. 97 2012 1443 1451
43. N. Olsen, T. Sokka, C.L. Seehorn, B. Kraft, K. Mass, J. Moore, and T.M. Aune A gene expression signature for recent onset rheumatoid arthritis in peripheral mononuclear cells Ann. Rheum. Dis. 63 2004 1387 1392
44. A.L. Agarwal, C. Monder, B. Eckstein, and P.C. White Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase J. Biol. Chem. 264 1989 18939 18943
45. E. Gomez-Sanchez Brain mineralocorticoid receptors in cognition and cardiovascular homeostasis Steroids 91 2014 20 31
46. R. Gong, D.J. Morris, and A.S. Brem 11β-Hydroxysteroid dehydrogenase (11β-HSD1 and 11β-HSD2) in Human Kidney: 11β-HSD1 co-localizes with COX-2 Life Sci. 82 2008 631 637
47. K.A. Hughes, K.N. Manolopoulos, J. Iqbal, N.L. Cruden, R.H. Stimson, R.M. Reynolds, D.E. Newby, R. Andrew, F. Karpe, and B.R. Walker Recycling between cortisol and cortisone in human splanchnic, subcutaneous adipose, and skeletal muscle tissues in vivo Diabetes 61 2012 1357 1364
48. N. Draper, E.A. Walker, I.J. Bujalska, J.W. Tomlinson, S.M. Chalder, W. Arlt, G.G. Lavery, O. Bedendo, D.W. Ray, I. Laing, E. Malunowicz, P.C. White, M. Hewison, P.J. Mason, J.M. Connell, C.H. Shackleton, and P.M. Stewart Mutations in the genes encoding type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency Nat. Genet. 34 2003 434 439
49. A.S. Brem, K. Matheson, J. Barnes, and D.J. Morris 11-Dehydrocorticosterone, a glucocorticoid metabolite, inhibits aldosterone action in the toad bladder Am. J. Physiol. (Renal Fluid and Electrolyte Physiol.) 261 1991 F873 F879
50. A.S. Brem, D.J. Morris, G. Yan, L. Dworkin, E. Tolbert, and R. Gong Direct fibrogenic effects of aldosterone on normotensive kidney: an effect modified by 11β-HSD activity Am. J. Physiol. (Renal Fluid and Electrolyte Physiol.) 298 2010 F1178 F1187
51. A. Odermatt, P. Arnold, and F.J. Frey The intracellular localization of the mineralocorticoid receptor is regulated by 11beta-hydroxysteroid dehydrogenase type 2 J. Biol. Chem. 276 2001 28484 28492
52. C. Monder, and V. Lakshmi Evidence for kinetically distinct forms of corticosteroid 11β-dehydrogenase in rat liver microsomes J. Steroid Biochem. 32 1989 77 83
53. S.A. Latif, H.A. Pardo, M.P. Hardy, and D.J. Morris Endogenous selective inhibitors of 11β-OH-steroid dehydrogenase isoforms 1 and 2 of adrenal origin Mol. Cell. Endocrinol. 243 2005 43 50
54. B.E. Pearson Murphy Demonstration of novel compounds in human fetal tissue and a consideration of their possible role in parturition Am. J. Obstet. Gynecol. 139 1981 353 358
55. D.J. Morris, S.A. Latif, W.E.B. Semafuko, B. Vogel, and M.F. Sheff Detection of glycyrrhetinic acid, liquorice-like factors (GALF's) in human urine Hypertension 20 1992 356 360
56. D.J. Morris, Y.H. Lo, W.R. Lichtfield, and G.W. Williams Impact of dietary Na+ on glycyrrhetinic acid-like factors (kidney-11β-HSD2 GALFs) in human essential hypertension Hypertension 31 1998 469 472
57. A.E. Michael, L. Gregory, S.M. Walker, J.W. Antoniw, R.W. Shaw, C.R.W. Edwards, and B.A. Cooke Ovarian 11β-hydroxysteroid dehydrogenase: potential predictor of conception by in vitro fertilization and embryo transfer Lancet 342 1993 711 712
58. L.M. Thurston, D.P. Norgate, K.C. Jonas, L. Gregory, P.J. Wood, B.A. Cooke, and A.E. Michael Ovarian modulators of type 1 11β-hydroxysteroid dehydrogenase (11β-HSD) activity and intra-follicular cortisol: cortisone ratios correlate with the clinical outcome of IVF Hum. Reprod. 18 2003 1603 1612
59. S.A. Latif, M.F. Sheff, C.E. Ribeiro, and D.J. Morris 11β-hydroxysteroid dehydrogenase (11β-HSD) Isoform 2 from sheep kidney is selectively inhibited by 5α-metabolites (but not 5β-metabolites) of adrenal cortex Steroids 62 1997 230 237
60. D.J. Morris, S.A. Latif, M.P. Hardy, and A.S. Brem Endogenous inhibitors (GALFs) of 11β-OH-Steroid dehydrogenase isoforms 1 and 2; derivatives of adrenally produced corticosterone and cortisol J. Steroid Biochem. Mol. Biol. 104 2007 161 168
61. G.W. Oertel, and K. Eik-Nes Isolation and identification of 11Keto-progesterone, 11βOH-progesterone, and 11βOH-androstenedione in canine adrenal vein blood Endocrinology 70 1962 39 42
62. R.B. Heap, M. Holzbauer, and H.M. Newport Adrenal secretion rates of C-19 and C-21 steroids before and after hypophysectomy in the pig and the dog J. Endocrinol. 36 1966 159 176
63. M.-E. Rafestin-Oblin, J. Fagart, A. Souque, C. Seguin, M. Bens, and A. Vandewalle 11β-Hydroxyprogesterone acts as a mineralocorticoid agonist in stimulating Na+ absorption in mammalian principal cortical collecting duct cells Mol. Pharmacol. 62 2002 1306 1313
64. S.D. Feighner, and P.B. Hylemon Characterization of a corticosteroid 21-dehydroxylase from the intestinal bacterium, Eubacterium lentum J. Lipid Res. 21 1980 585 593
65. J. Honour The possible involvement of intestinal bacteria in steroidal hypertension Endocrinology 110 1982 285 287
66. J. Honour, S.P. Borriello, U. Ganten, and P. Honour Antibiotics attenuate experimental hypertension in rats J. Endocrinol. 105 1985 347 350
67. D. Fraillon, K.N. Wynne, and J.W. Funder Further studies on neomycin and experimental hypertension Clin. Exp. Pharmacol. Physiol. 11 1984 339 342
68. E.G. Biglieri, M.A. Herron, and N. Brust 17-Hydroxylation deficiency in man J. Clin. Invest. 45 1966 1946 1954
69. R. Aachus, Genetic Deficiencies of Cytochrome P450c17(CYP17A1): Combined 17-hydroxylase/17,20-lyase deficiency and isolated 17,20-lyase deficiency, in: M.I. New (Editor-in chief), Genetic Steroid Disorders, 2014, pp. 111-123.
70. E.G. Biglieri, and F. Mantero The characteristics, course, and implication of the 17-hydroxylation deficiency in man M. Finkelstein, Research in Steroids, V 1977 Societa Editrice Universo Roma 385 399
71. S.R. Mallin Congenital adrenal hyperplasia secondary to 17-hydroxylase deficiency: two sisters with amenorrhea, hypokalemia, hypertension, and cystic ovaries Ann. Intern. Med. 70 1969 69 75
72. M.I. New Male pseudohermaphroditism due to 17-hydroxylase deficiency J. Clin. Invest. 49 1970 1930 1941
73. O. Goldsmith, D.H. Solomon, and R. Horton Hypogonadism and mineralocorticoid excess. The 17-hydroxylase deficiency syndrome NEJM 277 1967 673 677
74. D.J. Morris, S.A. Latif, and A.S. Brem An alternative explanation of hypertension associated with 17-hydroxylase deficiency syndrome Steroids 79 2014 44 48
75. T.E. Chapman, G.P.B. Kraan, G.T. Nagel, B.G. Wolthers, and N.M. Drayer Measurement of the cortisol production rate in two sisters with 17-hydroxylase deficiency using [1,2,3,4-13C] cortisol and isotope dilution mass spectrometry J. Steroid Biochem. 38 1991 489 496
76. B.P. Lisboa, J.M. Halket, I. Ganschow, and C. Ruiz-Gonzalez Steroid excretion in a case of 17-hydroxylase deficiency investigated by computerized gas chromatography-mass spectrometry Acta Med. Port. 1 1979 433 449
77. G.W. Souness, and D.J. Morris 11α- and 11β-Hydroxyprogesterone, potent inhibitors of 11β-hydroxysteroid dehydrogenase, possess hypertensinogenic activity in the rat Hypertension 27 1996 421 425
78. D.J. Morris, and G.W. Souness Endogenous 11 beta-hydroxysteroid dehydrogenase inhibitors and their role in glucocorticoid Na+ retention and hypertension Endocrinol. Res. 22 1995 793 801
79. S. Ulick, L.S. Levine, P. Gunczler, G. Zanconato, L.C. Ramirez, W. Rauh, A. Rosler, and H.L. Bradlow A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol J. Clin. Endocrinol. Metab. 49 1979 757 764
80. P.C. White, T. Mune, and A.K. Agarwal 11β-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess Endocrinol. Rev. 18 1997 135 156
81. A. Soro, M.C. Ingram, G. Tonolo, N. Glorioso, and R. Fraser Evidence of coexisting changes in 11β-hydroxysteroid dehydrogenase and 5β-reductase activity in subjects with untreated essential hypertension Hypertension 25 1995 67 70
82. J. Gorsline, S.A. Latif, and D.J. Morris Changes in 5α-and 5ß-reductase pathways of aldosterone metabolism by dietary sodium Am. J. Hypertension 1 1988 272 275
83. S. Dave-Sharma, R.C. Wilson, M.D. Harbison, R. Newfield, M.R. Azar, Z.S. Krozowski, J.W. Funder, C.H.L. Shackleton, H.L. Bradlow, J.-Q. Wei, J. Hertecant, J.A. Moran, R.E. Neiberger, J.W. JBalfe, A. Fattah, D. Daneman, H.I. Akkurt, C. De Santis, and M.I. New Extensive personal experience examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess J. Clin. Endocrinol. Metab. 83 1998 2244 2254
84. I. Lo, W.S. Semafuko, S.A. Latif, M.I. New, D.J. Morris, unpublished observations.
85. B.R. Walker, P.M. Stewart, C.H.L. Shackleton, P.L. Padfield, and C.R.W. Edwards Deficient inactivation of cortisol by 11β-hydroxysteroid dehydrogenase in essential hypertension Clin. Endocrinol. 39 1993 221 227
86. A.M. Briones, A. Nguyen Dinh Cat, G.E. Callera, A. Yogi, D Burger, Y. He, J.W. Corrêa, A.M. Gagnon, C.E. Gomez-Sanchez, E.P. Gomez-Sanchez, A. Sorisky, T.C. Ooi, M. Ruzicka, K.D. Burns, and R.M. Touyz Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction Hypertension 59 2012 1069 1078
87. S.M. MacKenzie, M.C. Connell, and E. Davies Non-adrenal synthesis of aldosterone: a reality check Mol. Cell Endocrinol. 350 2012 163 167
88. C.A. Winkel, E.R. Simpson, L. Milewich, and P.C. MacDonald Deoxycorticosterone biosynthesis in human kidney: potential for formation of a potent mineralocorticoid in its site of action Proc. Natl. Acad. Sci. 77 1981 7069 7073
89. B.E. Pearson Murphy, S.I. Steinberg, F.-Y. Hu, and C.M. Allison Neuroactive Ring A-reduced metabolites of progesterone in human plasma during pregnancy: elevated levels of 5α-dihydroprogesterone in depressed patients during the latter half of pregnancy J. Clin. Endocrinol. Metab. 86 2001 5981 5987
90. M.J. McDermott, M. Freiberger, S.A. Latif, and D.J. Morris The synthesis of reduced metabolites of aldosterone by subcellular fractions of rat kidney: effects of anti-mineralocorticoids J. Steroid Biochem. 23 1985 503 509
91. P.J. Raubenheimer, E.A. Young, R. Andrew, and J.R. Seckl The role of corticosterone in human hypothalamic-pituitary-adrenal axis feedback Clin. Endocrinol. 65 2006 22 26
92. L.J. Lewis-Tuffin, and J.A. Cidlowski The physiology of human glucocorticoid receptor β (hGRβ) and glucocorticoid resistance Ann. N.Y. Acad. Sci. 1069 2006 1 9
93. E.A. Lannan, A.J. Galliher-Beckley, A.B. Scoltock, and J.A. Cidlowski Pro-inflammatory actions of glucocorticoids: glucocorticoids and TNFα coregulate gene expression in vitro and in vivo Endocrinology 153 2012 3701 3712
94. R. Glaser, and J.K. Kiecolt-Glaser Stress-induced immune dysfunction: implications for health Nat. Rev. Immunol. 5 2005 243 251
95. L. Pascual-Le Tallec, O. Kirsh, M.-C. Marie-Christine Lecomte, S. Viengchareun, M.-C. Zennaro, A. Dejean, and M. Lombes Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification Mol. Endocrinol. 17 2003 2529 2542
96. R.M. Sapolsky, L.M. Romero, and A.U. Munck How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions Endocrinol. Rev. 21 2000 55 89
97. J. Li, H.N. Motlagh, C. Chakuroff, E.B. Thompson, and V.J. Hilser Thermodynamic dissection of the intrinsically disordered N-terminal domain of human glucocorticoid receptor J. Biol. Chem. 287 2012 26777 26787
98. A. Munck Glucocorticoid biology; a historical perspective N.J. Goulding, R.J. Flower, Glucocorticoids 2001 Birkhauser Verlag 17